Remember Me
Or use your Academic/Social account:


Or use your Academic/Social account:


You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.


Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message


Verify Password:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Arteaga, A.; Dhand, N.K.; McCann, T.; Knottenbelt, C.M.; Tebb, A.J.; Evans, H.; Eckersall, P.D.; Ramsey, I.K. (2010)
Publisher: Wiley-Blackwell Publishing Ltd.
Languages: English
Types: Article
Subjects: SF600
Background: Acute phase proteins (APPS) include haptoglobin (Hp), C-reactive protein (CRP) and serum amyloid A (SAA). Increased Hp concentrations may be induced by endogenous or exogenous glucocorticoids in dogs.\ud \ud Objectives: To assess whether control of hyperadrenocorticism (HAC) affects the concentrations of Hp, CRP, SAA, alkaline phosphatase (ALKP) and cholesterol, to determine whether these analytes can be used to assess control of HAC following trilostane treatment, and whether a combination of these tests offers a valid method of assessing disease control.\ud \ud Methods: Hp, CRP, SAA, ALKP and cholesterol were assessed in 11 dogs with spontaneous HAC before and after treatment with trilostane. Adequate control of HAC was defined as post-ACTH cortisol less than 150 nmol/l.\ud \ud Results: Significant reductions in Hp, ALKP, cholesterol and SAA (P<0·05) but not of CRP were found after control of HAC. Only Hp, cholesterol and ALKP were moderately informative (Se & Sp>0·7) of disease control when compared to adrenocorticotropin or corticotropin (ACTH) stimulation test. SAA and CRP were unhelpful (Se & Sp<0·7). The analysis of the combination of the analytes did not improve the correlation with ACTH stimulation test.\ud \ud Clinical Relevance: Relying on these analytes does not provide additional information over ACTH stimulation test results when assessing control of HAC treated with trilostane.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 3. Braddock JA, Church DB, Robertson ID, Watson ADJ. (2003) Trilostane treatment in dogs with pituitary-dependent hyperadrenocorticism. Australian Veterinary Journal 8, 600-607
    • 4. Ceron JJ, Eckersall PD, Martinez-Subiela S. (2005) Acute phase proteins in dogs and cats: current knowledge and future perspectives. Veterinary Clinical Pathology 34, 85-99
    • 5. Child JA, Cooper Eh, Illingworth S, Worthy TS. (1978) Biological markers in Hodgkin's disease and non-Hodgkin's lymphoma. Recent Results in Cancer Research 64, 180-189
    • 6. Dohoo, I. R., S. W. Martin, and H. Stryhn. (2003) Veterinary Epidemiologic Research. 1st ed, Charlottetown, PEI, Canada, AVC
    • 7. Dunn KJ, Herrtage RME, Dunn JK. (1995) Use of ACTH stimulation test to monitor treatment of canine hypereadrenocorticism. Veterinary Record 137, 161-175 v i
    • 8. Eckersall PD, Duthie S, Safi S, eMoffat D, Horadagoda NU, Doyle S, Parton R, w Bennet D & Fitzpatrick JL (1999a) An automated biochemical assay for Haptoglobin: prevention of interference from Calbumin. Comparative haematology International 9, 117-124. o p 9..Eckersall PD, Duthie S, Toussaint JM, Gruys E, Heeygaard P, Alava M, Lipperheide C, Madec F. (1999) Standarization of diagnostic assays for animal acute phase proteins. Advances in Veterinary Medicine 41, 643-655
    • 10. Feldman EC, Nelson RW. (2004) Canine hyperadrenocorticism (Cushing's syndrome). In: Canine and feline endocrinology and reproduction. 3rd edn. Eds E.C. Feldman and R.W. Nelson RW. W.B. Saunders; St. Louis pp 252-358
    • 11. Greiner M, Pfeiffer D, Smith RD. (2000) Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests Preventive Veterinary Medicine 45,23-41
    • 12. Harvey JW, West CL. (1987) Prednisolone-induced increases in serum alpha-2- globulin and Haptoglobin concentration in dogs. Veterinary Pathology 24, 90-92
    • 17. Ling GV, Stabenfeldt GH, Comer KM, Gribble DH, Schechter RD. (1979) Canine hyperadrenocorticism: Pretreatment clinical and laboratory evaluation of 117 cases. Journal of the American Veterinary Medicine Association 174, 1211-1214
    • 18. Martinez-Subiela S, Ginel PJ, Ceron JJ. (2004) Effects of different glucocorticoid treatments on serum acute phase proteins in dogs. Veterinary Record 154, 814-817
    • 19. Martinez-Subiela S, Ceron JJ. (2005) Effects of hemolysis, lipemia, hyperbilirubinaemia, and anticoagulants in canine C-reactive protein, serum Amyloid A, and ceruloplasmin assays. Canadian Veterinary Journal 46, 625-629
    • 20. Mischke R, Waterston M, Eckersall PD. (2007) Changes in C-reactive protein and haptoglobin in dogs wRithlymphatic neoplasia. Veterinary Journal 174, 188-192. e
    • 21. McGrottyYL, KnottenbevltCM, Ramsey IK, Reid SWJ, Eckersall PD. (2003) i Haptoglobin concentrations in a ceanine hospital population. Veterinary Record 152, 562-564 w C
    • 22. McGrottyYL, Arteaga A, Knottenbelt CM, oRamsey IK, Eckersall PD. (2005) Haptoglobin concentrations in dogs undergoing trilpostane treatment for hyperadrenocorticism. Veterinary Clinical Pathology 4y3,255-258
    • 23. Meijer JC. (1980) Canine Hyperadrenocorticism. In: Current Veterinary Therapy VII. R.W. Kirk ed. W.B. Saunders; Philadelphia pp 975-979
    • 24. Neiger R, Ramsey IK, O'Connor J, Hurley KJ, Mooney CT. (2002) Trilostane treatment of 78 dogs with pituitary-dependent hyperadrenocorticism. Veterinary Record 150, 799-804
    • 25. Neiger R, Hurley K. (2001) 24 hour cortisol values in dogs with Hyperadrenocorticism on trilostane. Proceedings of the 44th British Small Animal Veterinary Association Conference. Birmingham, UK. pp 549.
    • 26. Jack Oliver. Steroid profiles in the diagnosis of canine adrenal disorders. Proceedings of the 25th ACVIM Forum, Seattle, WA, USA, pp 471-473
    • 27. Onishi T, Inokuma H, Ohno K, at al. (2000) C-reactive protein concentrations in normal and diseased dRogs-measured by laser nephelometric immunoassay. Journal of Japanese Veterinary Medeicine Association 53, 595-601 v i
    • 28. Perez-Alenza D, Arenas C, Loepez ML, Melian C. (2006) Long term efficacy of w trilostane administered twice daily in dogs with pituitary dependent hyperadrenocorticism. Journal of the AmerCican Animal Hospital Association 42, 269- 276 o p
    • 29. Reusch CE, Feldman EC. Canine hyperadrenocortiycism due to adrenocortical neoplasia: pre-treatment evaluation of 41 dogs. (1991) Journal of Veterinary Internal Medicine 5, 3-10
    • 30. Ruckstuhl NS, Nett CS, Reusch CE. (2002) Results of clinical examinations, laboratory tests, and ultrasonography in dogs with pituitary-dependent hyperadrenocorticism treated with trilostane. American Journal of Veterinary Research 63, 506-510
    • 35. Thomson D, Milford-Ward A, Wicher J. (1992) The value of acute phase measurements in clinical practice. Annuals of Clinical Biochemistry 29, 123-131
    • 36. Vaessen MAR, Kooistra HS, Mol JA, Rijnberk A. (2004) Urinary corticoid: creatinine ratios in healthy pet dogs after oral low-dose dexamethasone suppression test. Veterinary Record 155, 518-521
    • 37. Wilson SM, Feldman EC. (1992) Diagnostic value of steroid-induced isoenzyme of alkaline phosphatase in the dog. Journal of the American Animal Hospital Association 28, 245-250
  • No related research data.
  • Discovered through pilot similarity algorithms. Send us your feedback.

Share - Bookmark

Cite this article